Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 45 years, Yale Cancer Center is one of only 51 Centers in the nation.
Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.
The physicians, nurses, scientists, and staff at Yale Cancer Center are leaders in cancer research and care. Cancer treatment for patients is available at Smilow Cancer Hospital through multidisciplinary teams who work together to make sure that every aspect of a patient’s treatment plan is well managed. Smilow Cancer Hospital is accredited by the Commission on Cancer, a Quality program of the American College of Surgeons.
Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.
A world leader in cancer care, research and education, Yale Cancer Center delivers the transformative scientific discoveries and care innovations of Smilow Cancer Hospital and Yale University to bring us closer to a world free of cancer – one patient at a time.
- Provide expert, evidence-based, compassionate care to patients and families.
- Conduct basic, translational, population, and clinical research to advance diagnosis, prevention, treatment, and cure.
- Design programs that promote public health, particularly among high-risk and underserved populations.
- Disseminate innovation throughout the world.
- Train next generation of leaders in cancer care and research.
- Promote an inclusive and diverse cancer community where all individuals are valued and respected.